Malaria Vaccination

Vaccinal malaria is a form of the disease that is caused by the bite of Anopheles mosquitoes. It is a type of malaria that can be prevented by vaccination.

The history of the study of malaria disease and the creation of a vaccine began in the 19th century. The first attempts were made by Francois Figet in the late 80s of the 19th century, and in 1901 the scientist isolated an antigen from the blood of a sick person, which gave rise to the development of a vaccine.

Currently, the modern vaccine against inoculum malaria includes the components necessary to immunize humans against anaplasmosis (a disease caused by Anopheles gambiae) and plasmodium (the causative agent of malaria).

The vaccine is part of the standard malaria prevention package in regions such as Africa and South America. Since 2010, the vaccine has provided comprehensive protection against the three main malaria pathogens: Plasmodium falciparum, Plasmodia vivax and Plasmodiun malariae.

An analysis of the effectiveness of such protection showed that after vaccination, immunity persists for more than a year, while the effectiveness of additional protection is more than 95%. What makes this vaccine particularly effective for population control of malaria.